Jonathan Mc Neill Dyne Therapeutics, Inc. (DYN) insider trading activity

Jonathan Mc Neill is Chief Business Officer of Dyne Therapeutics, Inc.. Currently has a direct ownership of 132,106 shares of DYN, which is worth approximately $1.98 Million. The most recent transaction as insider was on Mar 14, 2023, when has been sold 1,209 shares (Common Stock) at a price of $13.33 per share, resulting in proceeds of $16,115. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 132K

0% 3M change

8.02% 12M change

Total Value Held $1.98 Million

Jonathan McNeill Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 14 2023	SELL Open market or private sale	$16,115 $13.33 p/Share	1,209 Reduced 1.82%	65,391 Common Stock
Mar 13 2023	SELL Open market or private sale	$13,000 $13.0 p/Share	1,000 Reduced 1.48%	66,600 Common Stock
Jan 18 2023	SELL Open market or private sale	$140,300 $14.03 p/Share	10,000 Reduced 12.89%	67,600 Common Stock
Jan 18 2023	BUY Exercise of conversion of derivative security	$7,300 $0.73 p/Share	10,000 Added 11.42%	77,600 Common Stock
Jan 09 2023	SELL Open market or private sale	$348,835 $11.57 p/Share	30,150 Reduced 30.84%	67,600 Common Stock
Dec 12 2022	SELL Open market or private sale	$5,130 $10.87 p/Share	472 Reduced 0.48%	97,750 Common Stock
Dec 09 2022	BUY Grant, award, or other acquisition	-	40,000 Added 28.94%	98,222 Common Stock
Sep 20 2022	SELL Sale (or disposition) back to the issuer	$17,070 $13.7 p/Share	1,246 Reduced 2.1%	58,222 Common Stock
Sep 15 2022	SELL Sale (or disposition) back to the issuer	$6,941 $14.05 p/Share	494 Reduced 0.82%	59,468 Common Stock
Jun 14 2022	SELL Sale (or disposition) back to the issuer	$2,495 $4.95 p/Share	504 Reduced 0.83%	59,962 Common Stock
Mar 11 2022	SELL Open market or private sale	$4,199 $8.73 p/Share	481 Reduced 0.79%	60,466 Common Stock
Dec 10 2021	BUY Grant, award, or other acquisition	-	25,311 Added 29.34%	60,947 Common Stock
Sep 21 2021	SELL Open market or private sale	$11,744 $16.11 p/Share	729 Reduced 2.0%	35,636 Common Stock
Sep 20 2021	SELL Open market or private sale	$8,507 $15.61 p/Share	545 Reduced 1.48%	36,365 Common Stock

Jonathan Mc Neill

Chief Business Officer

Waltham, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DYN shares.

Notify only if

Value

Insider Trading

Get notified when an Dyne Therapeutics, Inc. insider buys or sells DYN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Dyne Therapeutics, Inc.

Track Activities on DYN

Account